{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T14:04:35Z","timestamp":1784988275313,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Centre Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Familial Mediterranean Fever (FMF) is an inherited autoinflammatory disease characterized by recurrent episodes of fever and serositis caused by mutations in the MEFV gene. FMF primarily affects individuals of Mediterranean ancestry. Typical manifestations include short-lasting attacks of abdominal pain, chest pain, and arthritis. Long-term complications, such as amyloidosis, might be prevented with colchicine treatment. This study aimed to assess the clinical, demographic and molecular features of FMF in Egyptian patients. This multicenter prospective study included 280 clinically suspected FMF patients referred to the outpatient clinics of participating centers. Patients were enrolled based on recurrent episodes of fever and abdominal pain suggestive of FMF. The diagnosis of FMF was established based on the Eurofever\/PRINTO criteria, in addition to molecular genetic confirmation of MEFV mutations. Patients who did not meet diagnostic criteria were excluded. The study included 173 female patients, and 107 male patients with age range from 2 up to 60 years. All patients were descending from different families. Parental consanguinity was found in 24.6% while positive family history was seen in 33.2%. The duration of the attack in almost two third of the patients was less than 48\u00a0h, only 6% of the patients suffered attacks longer than 72\u00a0h. About half the patients achieved a marked reduction or complete cessation of FMF attacks, along with normalization or significant reduction of inflammatory markers (e.g., serum amyloid A), following colchicine therapy at a daily dose of 1.5\u20133\u00a0mg., only 6% needed higher doses. The initial serum amyloid A was normal in 47.5% in the patients and elevated in the remaining patients. Fever was documented in only 19.6% of patients at presentation; abdominal pain was among the most common presentation, seen in 62.1%. The most frequently observed MEFV allele was E148Q (143, 39.5%) followed by M694I (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200959, 16.3%), A744S and V726A (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200944, 12.2% for each), then M680I (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200935, 9.7%). In our multicenter study focused on Egyptians, 93.6% of the enrolled FMF patients carried at least one MEFV variant. The E148Q allele was the most frequently observed followed by M694I. The study also revealed that Egyptian patients exhibited a mild form of the disease with a female predominance. This mild presentation might be attributed to the high E148Q prevalence and low rate of amyloidosis in our cohort.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-55905-y","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T13:34:19Z","timestamp":1784986459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinico-demographic and molecular characteristics of familial Mediterranean fever in Egypt: a multicenter study"],"prefix":"10.1038","volume":"16","author":[{"given":"Mohamed","family":"Elbadry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha H.","family":"Eltaweel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Hussein","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya M.","family":"Mahros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fathiya","family":"El-Raey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamardan","family":"Bazeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanaa","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Shamardan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Hagag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimaa","family":"Arafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa","family":"Bakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Tahoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Zaky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"issue":"1","key":"55905_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.semarthrit.2019.08.004","volume":"50","author":"E Sag","year":"2020","unstructured":"Sag, E. et al. Performance of the new \u2018Eurofever\/PRINTO classification criteria\u2019 in FMF patients. Semin Arthritis Rheum. 50 (1), 172\u2013175. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.08.004 (2020).","journal-title":"Semin Arthritis Rheum."},{"issue":"2","key":"55905_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/rheumatology\/kead439","volume":"63","author":"E Ben-Chetrit","year":"2023","unstructured":"Ben-Chetrit, E. Old paradigms and new concepts in familial Mediterranean fever (FMF): an update 2023. Rheumatology 63 (2), 309\u2013318. https:\/\/doi.org\/10.1093\/rheumatology\/kead439 (2023).","journal-title":"Rheumatology"},{"issue":"3","key":"55905_CR3","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/rheumatology\/kez334","volume":"59","author":"DM Rowczenio","year":"2019","unstructured":"Rowczenio, D. M. et al. British kindred with dominant FMF associated with high incidence of AA amyloidosis caused by novel MEFV variant, and a review of the literature. Rheumatology 59 (3), 554\u2013558. https:\/\/doi.org\/10.1093\/rheumatology\/kez334 (2019).","journal-title":"Rheumatology"},{"key":"55905_CR4","doi-asserted-by":"publisher","unstructured":"Gallego, E. et al. Familial Mediterranean fever in Spain: Time trend and spatial distribution of the hospitalizations. Int. J. Environ. Res. Public. Health. 20 (5). https:\/\/doi.org\/10.3390\/ijerph20054374 (2023).","DOI":"10.3390\/ijerph20054374"},{"key":"55905_CR5","doi-asserted-by":"publisher","first-page":"624795","DOI":"10.3389\/fmed.2021.624795","volume":"8","author":"E Alpsoy","year":"2021","unstructured":"Alpsoy, E., Leccese, P., Emmi, G. & Ohno, S. Treatment of Beh\u00e7et\u2019s disease: an algorithmic multidisciplinary approach. Front. Med. 8, 624795 (2021).","journal-title":"Front. Med."},{"key":"55905_CR6","doi-asserted-by":"publisher","unstructured":"Rech, J. et al. Patient Experiences and Challenges in the Management of Autoinflammatory Diseases\u2014Data from the International FMF & AID Global Association Survey. J. Clin. Med. 13 (5). https:\/\/doi.org\/10.3390\/jcm13051199 (2024).","DOI":"10.3390\/jcm13051199"},{"issue":"1","key":"55905_CR7","first-page":"266","volume":"3","author":"L Mahboobi","year":"2024","unstructured":"Mahboobi, L. & Shotorbani, B. S. Distribution of clinical findings in FMF patients in the acute phase of the disease. Eurasian J. Chem. Med. Pet. Res. 3 (1), 266\u2013275 (2024).","journal-title":"Eurasian J. Chem. Med. Pet. Res."},{"key":"55905_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.gene.2017.05.013","volume":"626","author":"N Cekin","year":"2017","unstructured":"Cekin, N., Akyurek, M. E., Pinarbasi, E. & Ozen, F. MEFV mutations and their relation to major clinical symptoms of Familial Mediterranean Fever. Gene 626, 9\u201313. https:\/\/doi.org\/10.1016\/j.gene.2017.05.013 (2017).","journal-title":"Gene"},{"issue":"1","key":"55905_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13052-019-0766-z","volume":"46","author":"MC Maggio","year":"2020","unstructured":"Maggio, M. C. & Corsello, G. FMF is not always fever: from clinical presentation to treat to target. Ital. J. Pediatr. 46 (1), 7. https:\/\/doi.org\/10.1186\/s13052-019-0766-z (2020).","journal-title":"Ital. J. Pediatr."},{"issue":"10","key":"55905_CR10","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.3906\/sag-2008-11","volume":"50","author":"A Tufan","year":"2020","unstructured":"Tufan, A. & LACHMANN, H. Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review. Turkish J. Med. Sci. 50 (10), 1591\u20131610 (2020).","journal-title":"Turkish J. Med. Sci."},{"issue":"4","key":"55905_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5152\/eurjrheum.2020.20107","volume":"7","author":"DY Kehribar","year":"2020","unstructured":"Kehribar, D. Y. & \u00d6zgen, M. The importance of Mediterranean fever gene in familial Mediterranean fever. Eur. J. Rheumatol. 7 (4), 173\u2013176. https:\/\/doi.org\/10.5152\/eurjrheum.2020.20107 (2020).","journal-title":"Eur. J. Rheumatol."},{"issue":"7","key":"55905_CR12","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.3390\/ijms23073956","volume":"23","author":"E Giat","year":"2022","unstructured":"Giat, E., Ben-Zvi, I., Lidar, M. & Livneh, A. The preferential use of anakinra in various settings of FMF: a review applied to an updated treatment-related perspective of the disease. Int. J. Mol. Sci. 23 (7), 3956 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"55905_CR13","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/S00296-009-1140-Z","volume":"30","author":"A El-Garf","year":"2010","unstructured":"El-Garf, A., Salah, S., Iskander, I., Salah, H. & Amin, S. N. MEFV mutations in Egyptian patients suffering from familial Mediterranean fever: analysis of 12 gene mutations. Rheumatol. Int. 30 (10), 1293\u20131298. https:\/\/doi.org\/10.1007\/S00296-009-1140-Z (2010).","journal-title":"Rheumatol. Int."},{"issue":"9","key":"55905_CR14","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/SJ.EJHG.5201869","volume":"15","author":"L Yepiskoposyan","year":"2007","unstructured":"Yepiskoposyan, L. & Harutyunyan, A. Population genetics of familial Mediterranean fever: a review. Eur. J. Hum. Genet. 15 (9), 911\u2013916. https:\/\/doi.org\/10.1038\/SJ.EJHG.5201869 (2007).","journal-title":"Eur. J. Hum. Genet."},{"issue":"1","key":"55905_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3899\/JRHEUM.090273","volume":"37","author":"O Soylemezoglu","year":"2010","unstructured":"Soylemezoglu, O. et al. Unresponsiveness to colchicine therapy in patients with familial Mediterranean fever homozygous for the M694V mutation. J. Rheumatol. 37 (1), 182\u2013189. https:\/\/doi.org\/10.3899\/JRHEUM.090273 (2010).","journal-title":"J. Rheumatol."},{"key":"55905_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/J.ARD.2025.05.020","author":"E Sag","year":"2025","unstructured":"Sag, E., Ot\u00f3n, T., Carmona, L. & Ozen, S. Efficacy and safety of treatments in familial Mediterranean fever and its complications: a systematic review informing the EULAR\/PReS recommendations for familial Mediterranean fever. Ann. Rheum. Dis. Published online. https:\/\/doi.org\/10.1016\/J.ARD.2025.05.020 (2025).","journal-title":"Ann. Rheum. Dis. Published online"},{"key":"55905_CR17","doi-asserted-by":"publisher","unstructured":"Hentgen, V., Vinit, C., Fayand, A. & Georgin-Lavialle, S. The use of interleukine-1 inhibitors in familial mediterranean fever patients: A narrative review. Front. Immunol. 11 https:\/\/doi.org\/10.3389\/FIMMU.2020.00971 (2020).","DOI":"10.3389\/FIMMU.2020.00971"},{"issue":"67","key":"55905_CR18","first-page":"S87","volume":"29","author":"F Yalcinkaya","year":"2011","unstructured":"Yalcinkaya, F., \u00d6z\u00e7akar, Z. & Tany\\ild\\iz, M. others. Paediatric rheumatology Familial Mediterranean fever in small children in Turkey. Clin. Exp. Rheumatol. 29 (67), S87\u2013S90 (2011).","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"55905_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00296-018-4123-0","volume":"39","author":"HE S\u00f6nmez","year":"2019","unstructured":"S\u00f6nmez, H. E. et al. Is age associated with disease severity and compliance to treatment in children with familial Mediterranean fever? Rheumatol. Int. 39 (1), 83\u201387. https:\/\/doi.org\/10.1007\/s00296-018-4123-0 (2019).","journal-title":"Rheumatol. Int."},{"issue":"2","key":"55905_CR20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.31138\/MJR.31.2.206","volume":"31","author":"HS Talaat","year":"2020","unstructured":"Talaat, H. S. et al. Genotype Mutations in Egyptian Children with Familial Mediterranean Fever: Clinical Profile, and Response to Colchicine. Mediterr. J. Rheumatol. 31 (2), 206\u2013213. https:\/\/doi.org\/10.31138\/MJR.31.2.206 (2020).","journal-title":"Mediterr. J. Rheumatol."},{"issue":"3","key":"55905_CR21","doi-asserted-by":"publisher","first-page":"332","DOI":"10.31138\/MJR.20230912.STM","volume":"34","author":"ON Shrateh","year":"2023","unstructured":"Shrateh, O. N. et al. Genotype Mutations in Palestinian Children with Familial Mediterranean Fever: Clinical Profile, and Response to Colchicine Treatment: A Retrospective Cohort Study. Mediterr. J. Rheumatol. 34 (3), 332. https:\/\/doi.org\/10.31138\/MJR.20230912.STM (2023).","journal-title":"Mediterr. J. Rheumatol."},{"issue":"2","key":"55905_CR22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/J.1442-200X.2008.02554.X","volume":"50","author":"R Du\u015funsel","year":"2008","unstructured":"Du\u015funsel, R. et al. Genotype-phenotype correlation in children with familial Mediterranean fever in a Turkish population. Pediatr. Int. 50 (2), 208\u2013212. https:\/\/doi.org\/10.1111\/J.1442-200X.2008.02554.X (2008).","journal-title":"Pediatr. Int."},{"issue":"1","key":"55905_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.MD.0000152370.84628.0C","volume":"84","author":"M Tunca","year":"2005","unstructured":"Tunca, M. et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Med. (Baltim). 84 (1), 1\u201311. https:\/\/doi.org\/10.1097\/01.MD.0000152370.84628.0C (2005).","journal-title":"Med. (Baltim)."},{"issue":"9515","key":"55905_CR24","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/S0140-6736(06)68430-4","volume":"367","author":"H El-Shanti","year":"2006","unstructured":"El-Shanti, H., Majeed, H. A. & El-Khateeb, M. Familial mediterranean fever in Arabs. Lancet (London England). 367 (9515), 1016\u20131024. https:\/\/doi.org\/10.1016\/S0140-6736(06)68430-4 (2006).","journal-title":"Lancet (London England)"},{"issue":"4","key":"55905_CR25","doi-asserted-by":"publisher","first-page":"716","DOI":"10.17098\/amj.651961","volume":"19","author":"NS Yasar Bilge","year":"2019","unstructured":"Yasar Bilge, N. S., Bodakc\u0131, E., B\u0131lge, U. & Kasifoglu, T. Gender is not a Prognostic Factor for Familial Mediterranean Fever. Ankara Med. J. 19 (4), 716\u2013721. https:\/\/doi.org\/10.17098\/amj.651961 (2019).","journal-title":"Ankara Med. J."},{"issue":"Suppl 1","key":"55905_CR26","doi-asserted-by":"publisher","first-page":"959LP","DOI":"10.1136\/annrheumdis-2021-eular.2317","volume":"80","author":"MT Duru\u00f6z","year":"2021","unstructured":"Duru\u00f6z, M. T. et al. Ann. Rheum. Dis. ;80(Suppl 1):959LP\u2013960. doi:https:\/\/doi.org\/10.1136\/annrheumdis-2021-eular.2317 (2021).","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"55905_CR27","doi-asserted-by":"publisher","first-page":"240","DOI":"10.5114\/PG.2022.118595","volume":"17","author":"MH Ahmed","year":"2022","unstructured":"Ahmed, M. H., El Henawy, O., ElShennawy, E. M. & Mahros, A. M. Clinical and genetic characterization of familial Mediterranean fever among a cohort of Egyptian patients. Przeglad Gastroenterol. 17 (3), 240. https:\/\/doi.org\/10.5114\/PG.2022.118595 (2022).","journal-title":"Przeglad Gastroenterol."},{"issue":"1","key":"55905_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/S00296-020-04592-7","volume":"41","author":"NA Ayaz","year":"2021","unstructured":"Ayaz, N. A. et al. Comorbidities and phenotype-genotype correlation in children with familial Mediterranean fever. Rheumatol. Int. 41 (1), 113\u2013120. https:\/\/doi.org\/10.1007\/S00296-020-04592-7 (2021).","journal-title":"Rheumatol. Int."},{"issue":"1","key":"55905_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/S00296-020-04696-0","volume":"41","author":"K \u00d6zt\u00fcrk","year":"2021","unstructured":"\u00d6zt\u00fcrk, K. & \u00c7akan, M. Protracted febrile myalgia syndrome as the first manifestation of familial Mediterranean fever in children: case-based review. Rheumatol. Int. 41 (1), 213\u2013218. https:\/\/doi.org\/10.1007\/S00296-020-04696-0 (2021).","journal-title":"Rheumatol. Int."},{"issue":"5","key":"55905_CR30","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/QJMED\/95.5.332","volume":"95","author":"S Ozen","year":"2002","unstructured":"Ozen, S., Besbas, N., Bakkaloglu, A. & Yilmaz, E. Pyrin Q148 mutation and familial Mediterranean fever. QJM Int. J. Med. 95 (5), 332\u2013333. https:\/\/doi.org\/10.1093\/QJMED\/95.5.332 (2002).","journal-title":"QJM Int. J. Med."},{"issue":"4","key":"55905_CR31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0049-0172(91)90019-V","volume":"20","author":"E Ben-Chetrit","year":"1991","unstructured":"Ben-Chetrit, E. & Levy, M. Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years. Semin Arthritis Rheum. 20 (4), 241\u2013246. https:\/\/doi.org\/10.1016\/0049-0172(91)90019-V (1991).","journal-title":"Semin Arthritis Rheum."},{"issue":"8","key":"55905_CR32","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1093\/RHEUMATOLOGY\/KEAA863","volume":"60","author":"S \u00d6zen","year":"2021","unstructured":"\u00d6zen, S. et al. Defining colchicine resistance\/intolerance in patients with familial Mediterranean fever: a modified-Delphi consensus approach. Rheumatol. (Oxford). 60 (8), 3799\u20133808. https:\/\/doi.org\/10.1093\/RHEUMATOLOGY\/KEAA863 (2021).","journal-title":"Rheumatol. (Oxford)"},{"issue":"2","key":"55905_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1089\/GTMB.2009.0180","volume":"14","author":"DA El Gezery","year":"2010","unstructured":"El Gezery, D. A., Abou-Zeid, A. A., Hashad, D. I. & El-Sayegh, H. K. MEFV gene mutations in Egyptian patients with familial Mediterranean fever. Genet. Test. Mol. Biomarkers. 14 (2), 263\u2013268. https:\/\/doi.org\/10.1089\/GTMB.2009.0180 (2010).","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"55905_CR34","doi-asserted-by":"publisher","unstructured":"Abouzaid, M. et al. Oro-dental features in Egyptian patients with familial mediterranean fever. Spec. Care Dent. Published online Dec. 13 https:\/\/doi.org\/10.1111\/scd.12687 (2021).","DOI":"10.1111\/scd.12687"},{"key":"55905_CR35","doi-asserted-by":"publisher","unstructured":"El Roz, A., Ghssein, G., Khalaf, B., Fardoun, T. & Ibrahim, J. N. Spectrum of MEFV Variants and Genotypes among Clinically Diagnosed FMF Patients from Southern Lebanon. Med. Sci. (Basel Switzerland). 8 (3). https:\/\/doi.org\/10.3390\/MEDSCI8030035 (2020).","DOI":"10.3390\/MEDSCI8030035"},{"issue":"4","key":"55905_CR36","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/S00296-014-3116-X","volume":"35","author":"RA Jarjour","year":"2015","unstructured":"Jarjour, R. A. & Al-Berrawi, S. Familial Mediterranean fever in Syrian children: phenotype-genotype correlation. Rheumatol. Int. 35 (4), 629\u2013634. https:\/\/doi.org\/10.1007\/S00296-014-3116-X (2015).","journal-title":"Rheumatol. Int."},{"issue":"6","key":"55905_CR37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/J.EJMG.2006.03.002","volume":"49","author":"H Mattit","year":"2006","unstructured":"Mattit, H. et al. Familial Mediterranean fever in the Syrian population: gene mutation frequencies, carrier rates and phenotype-genotype correlation. Eur. J. Med. Genet. 49 (6), 481\u2013486. https:\/\/doi.org\/10.1016\/J.EJMG.2006.03.002 (2006).","journal-title":"Eur. J. Med. Genet."},{"issue":"6","key":"55905_CR38","doi-asserted-by":"publisher","first-page":"417","DOI":"10.5455\/MEDARH.2015.69.417-420","volume":"69","author":"LA Habahbeh","year":"2015","unstructured":"Habahbeh, L. A. et al. Genetic Profile of Patients with Familial Mediterranean Fever (FMF): Single Center Experience at King Hussein Medical Center (KHMC). Med Arch (Bosnia Herzegovina) ;69(6):417\u2013420. doi:https:\/\/doi.org\/10.5455\/MEDARH.2015.69.417-420 (2015).","journal-title":"Bosnia Herzegovina)"},{"issue":"4","key":"55905_CR39","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/S00296-010-1732-7","volume":"32","author":"L Belmahi","year":"2012","unstructured":"Belmahi, L., Cherkaoui, I. J., Hama, I. & Sefiani, A. MEFV mutations in Moroccan patients suffering from familial Mediterranean Fever. Rheumatol. Int. 32 (4), 981\u2013984. https:\/\/doi.org\/10.1007\/S00296-010-1732-7 (2012).","journal-title":"Rheumatol. Int."},{"issue":"6","key":"55905_CR40","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/J.SEMARTHRIT.2006.12.004","volume":"36","author":"HB Chaabouni","year":"2007","unstructured":"Chaabouni, H. B. et al. MEFV mutations in Tunisian patients suffering from familial Mediterranean fever. Semin Arthritis Rheum. 36 (6), 397\u2013401. https:\/\/doi.org\/10.1016\/J.SEMARTHRIT.2006.12.004 (2007).","journal-title":"Semin Arthritis Rheum."},{"issue":"2","key":"55905_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/J.CRVI.2005.11.005","volume":"329","author":"L Belmahi","year":"2006","unstructured":"Belmahi, L. et al. Prevalence and distribution of MEFV mutations among Arabs from the Maghreb patients suffering from familial Mediterranean fever. C R Biol. 329 (2), 71\u201374. https:\/\/doi.org\/10.1016\/J.CRVI.2005.11.005 (2006).","journal-title":"C R Biol."},{"issue":"3","key":"55905_CR42","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1007\/S11033-020-06040-Y\/TABLES\/3","volume":"48","author":"A Arpac\u0131","year":"2021","unstructured":"Arpac\u0131, A., Do\u011fan, S., Erdo\u011fan, H. F., El, \u00c7. & Cura, S. E. Presentation of a new mutation in FMF and evaluating the frequency of distribution of the MEFV gene mutation in our region with clinical findings. Mol. Biol. Rep. 48 (3), 2025\u20132033. https:\/\/doi.org\/10.1007\/S11033-020-06040-Y\/TABLES\/3 (2021).","journal-title":"Mol. Biol. Rep."},{"issue":"11","key":"55905_CR43","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1093\/RHEUMATOLOGY\/39.11.1275","volume":"39","author":"IK Paut","year":"2000","unstructured":"Paut, I. K. et al. Phenotype\u2013genotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of cutaneomucous features. Rheumatology 39 (11), 1275\u20131279. https:\/\/doi.org\/10.1093\/RHEUMATOLOGY\/39.11.1275 (2000).","journal-title":"Rheumatology"},{"issue":"4","key":"55905_CR44","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1080\/09674845.2010.11730320","volume":"67","author":"GH Ibrahim","year":"2010","unstructured":"Ibrahim, G. H. et al. Analysis of common MEFV mutations in Egyptian patients with familial Mediterranean fever: molecular characterisation of the disease. Br. J. Biomed. Sci. 67 (4), 202\u2013207. https:\/\/doi.org\/10.1080\/09674845.2010.11730320 (2010).","journal-title":"Br. J. Biomed. Sci."},{"key":"55905_CR45","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1136\/ANNRHEUMDIS-2019-EULAR.7098","volume":"78","author":"A Tanatar","year":"2019","unstructured":"Tanatar, A. et al. Ann. Rheum. Dis. ;78:1352. doi:https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2019-EULAR.7098 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"55905_CR46","doi-asserted-by":"publisher","unstructured":"Lofty, H. M. et al. Serum Amyloid A level in Egyptian children with familial mediterranean fever. Int. J. Rheumatol. 2016 https:\/\/doi.org\/10.1155\/2016\/7354018 (2016).","DOI":"10.1155\/2016\/7354018"},{"issue":"10","key":"55905_CR47","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1007\/S00431-024-05690-5","volume":"183","author":"E Orouk Awaad","year":"2024","unstructured":"Orouk Awaad, E. et al. E148Q variant: a familial Mediterranean fever-causing mutation or a sequence variant? Eur. J. Pediatr. 183 (10), 4499. https:\/\/doi.org\/10.1007\/S00431-024-05690-5 (2024).","journal-title":"Eur. J. Pediatr."},{"issue":"3","key":"55905_CR48","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/RHEUMATOLOGY\/KEAD376","volume":"63","author":"T Reygaerts","year":"2024","unstructured":"Reygaerts, T. et al. Pyrin variant E148Q potentiates inflammasome activation and the effect of pathogenic mutations in cis. Rheumatol. (Oxford). 63 (3), 882\u2013890. https:\/\/doi.org\/10.1093\/RHEUMATOLOGY\/KEAD376 (2024).","journal-title":"Rheumatol. (Oxford)"},{"issue":"2","key":"55905_CR49","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1515\/BJMG-2017-0020","volume":"20","author":"BD Coskun","year":"2017","unstructured":"Coskun, B. D., Kiraz, A., Sevinc, E., Baspinar, O. & Cakmak, E. Increased Frequency of MEFV Genes in Patients with Epigastric Pain Syndrome. Balkan J. Med. Genet. 20 (2), 51\u201358. https:\/\/doi.org\/10.1515\/BJMG-2017-0020 (2017).","journal-title":"Balkan J. Med. Genet."},{"issue":"2","key":"55905_CR50","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/J.GENE.2014.06.019","volume":"546","author":"R Gunesacar","year":"2014","unstructured":"Gunesacar, R., Celik, M. M., Arica, V., Elmacioglu, S. & Ozturk, O. H. Frequency of MEFV gene mutations in Hatay province, Mediterranean region of Turkey and report of a novel missense mutation (I247V). Gene 546 (2), 195\u2013199. https:\/\/doi.org\/10.1016\/J.GENE.2014.06.019 (2014).","journal-title":"Gene"},{"issue":"1","key":"55905_CR51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/J.GENE.2012.06.074","volume":"506","author":"S Yigit","year":"2012","unstructured":"Yigit, S. et al. Significance of MEFV gene R202Q polymorphism in Turkish familial Mediterranean fever patients. Gene 506 (1), 43\u201345. https:\/\/doi.org\/10.1016\/J.GENE.2012.06.074 (2012).","journal-title":"Gene"},{"issue":"2","key":"55905_CR52","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4103\/1110-1067.139764","volume":"39","author":"L ElMessery","year":"2014","unstructured":"ElMessery, L. & Elhagrasy, H. Study of MEFV gene R202Q polymorphism in Egyptian patients with familial Mediterranean fever. Egypt. J. Haematol. 39 (2), 64. https:\/\/doi.org\/10.4103\/1110-1067.139764 (2014).","journal-title":"Egypt. J. Haematol."},{"key":"55905_CR53","first-page":"204","volume":"38","author":"A \u00d6zt\u00fcrk","year":"2008","unstructured":"\u00d6zt\u00fcrk, A, \u00d6z\u00e7akar, B., Eki\u0307m, M. & Akar, N. Is MEFVGene Arg202Gln (605 G\u2009>\u2009A) A Disease-Causing Mutation? Turk. J. Med. Sci. 38, 204\u2013208 (2008)..","journal-title":"J. Med. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55905-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55905-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55905-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T13:52:21Z","timestamp":1784987541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55905-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55905"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-55905-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in strict accordance with international ethical guidelines, having received formal approval from the Helwan University Faculty of Medicine Ethics Committee (Approval No.: 139\u20132024). The ethical details are listed in the methods section. All methods were carried out in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23226"}}